{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T11:59:10Z","timestamp":1775303950752,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T00:00:00Z","timestamp":1544486400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1038\/s41390-018-0251-1","type":"journal-article","created":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T21:08:41Z","timestamp":1544476121000},"page":"885-894","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["IGF-1 alleviates serum IgG-induced neuronal cytolysis through PI3K signaling in children with opsoclonus-myoclonus syndrome and neuroblastoma"],"prefix":"10.1038","volume":"85","author":[{"given":"Xu","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Feng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Yun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan-Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,11]]},"reference":[{"key":"251_CR1","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.braindev.2014.10.010","volume":"37","author":"S Hasegawa","year":"2015","unstructured":"Hasegawa, S. et al. A nationwide survey of opsoclonus-myoclonus syndrome in Japanese children. Brain Dev. 37, 656\u2013660 (2015).","journal-title":"Brain Dev."},{"key":"251_CR2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1001\/jamaneurol.2015.4607","volume":"73","author":"T Armangue","year":"2016","unstructured":"Armangue, T. et al. Clinical and immunological features of opsoclonus-myoclonus syndrome in the era of neuronal cell surface antibodies. JAMA Neurol. 73, 417\u2013424 (2016).","journal-title":"JAMA Neurol."},{"key":"251_CR3","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jneuroim.2005.08.018","volume":"170","author":"M Korfei","year":"2005","unstructured":"Korfei, M. et al. Functional characterisation of autoantibodies from patients with pediatric opsoclonus-myoclonus-syndrome. J. Neuroimmunol. 170, 150\u2013157 (2005).","journal-title":"J. Neuroimmunol."},{"key":"251_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jneuroim.2008.05.033","volume":"201","author":"F Blaes","year":"2008","unstructured":"Blaes, F., Pike, M. G. & Lang, B. Autoantibodies in childhood opsoclonus-myoclonus syndrome. J. Neuroimmunol. 201, 221\u2013226 (2008).","journal-title":"J. Neuroimmunol."},{"key":"251_CR5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jneuroim.2015.10.022","volume":"289","author":"V Fuhlhuber","year":"2015","unstructured":"Fuhlhuber, V. et al. Autoantibody-mediated cytotoxicity in paediatric opsoclonus-myoclonus syndrome is dependent on ERK-1\/2 phophorylation. J. Neuroimmunol. 289, 182\u2013186 (2015).","journal-title":"J. Neuroimmunol."},{"key":"251_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jneuroim.2015.07.007","volume":"286","author":"JA Panzer","year":"2015","unstructured":"Panzer, J. A., Anand, R., Dalmau, J. & Lynch, D. R. Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndrome. J. Neuroimmunol. 286, 86 (2015).","journal-title":"J. Neuroimmunol."},{"key":"251_CR7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.33588\/rn.6206.2015428","volume":"62","author":"J Bravo","year":"2016","unstructured":"Bravo, J., Lopez-Almaraz, R., Mateos, M., Diaz, L. & Hernandez-Exposito, S. Neuropsychological profile in opsoclonus-myoclonus-ataxia syndrome presenting as neuroblastic tumours. Rev. Neurol. 62, 249\u2013257 (2016).","journal-title":"Rev. Neurol."},{"key":"251_CR8","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3389\/fneur.2017.00468","volume":"8","author":"MR Pranzatelli","year":"2017","unstructured":"Pranzatelli, M. R., Tate, E. D. & McGee, N. R. Demographic, clinical, and immunologic features of 389 children with opsoclonus-myoclonus syndrome: a cross-sectional study. Front Neurol. 8, 468 (2017).","journal-title":"Front Neurol."},{"key":"251_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s00415-016-8389-4","volume":"264","author":"SY Oh","year":"2017","unstructured":"Oh, S. Y. et al. Longitudinal multi-modal neuroimaging in opsoclonus-myoclonus syndrome. J. Neurol. 264, 512\u2013519 (2017).","journal-title":"J. Neurol."},{"key":"251_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/dmcn.12594","volume":"57","author":"G Anand","year":"2015","unstructured":"Anand, G. et al. Cerebellar and cortical abnormalities in paediatric opsoclonus-myoclonus syndrome. Dev. Med. Child Neurol. 57, 265\u2013272 (2015).","journal-title":"Dev. Med. Child Neurol."},{"key":"251_CR11","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.clineuro.2010.03.024","volume":"112","author":"N Kanjanasut","year":"2010","unstructured":"Kanjanasut, N., Phanthumchinda, K. & Bhidayasiri, R. HIV-related opsoclonus-myoclonus-ataxia syndrome: report on two cases. Clin. Neurol. Neurosurg. 112, 572\u2013574 (2010).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"251_CR12","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.clineuro.2008.03.005","volume":"110","author":"I Markakis","year":"2008","unstructured":"Markakis, I., Alexiou, E., Xifaras, M., Gekas, G. & Rombos, A. Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase. Clin. Neurol. Neurosurg. 110, 619\u2013621 (2008).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"251_CR13","doi-asserted-by":"publisher","first-page":"e714","DOI":"10.1212\/WNL.0000000000006035","volume":"91","author":"G Berridge","year":"2018","unstructured":"Berridge, G. et al. Glutamate receptor \u03b42 serum antibodies in pediatric opsoclonus myoclonus ataxia syndrome. Neurology 91, e714\u2013e723 (2018).","journal-title":"Neurology"},{"key":"251_CR14","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/j.neurobiolaging.2014.01.021","volume":"35","author":"W Kim","year":"2014","unstructured":"Kim, W. et al. miR-126 contributes to Parkinson\u2019s disease by dysregulating the insulin-like growth factor\/phosphoinositide 3-kinase signaling. Neurobiol. Aging 35, 1712\u20131721 (2014).","journal-title":"Neurobiol. Aging"},{"key":"251_CR15","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1242\/jcs.02490","volume":"118","author":"L Laurino","year":"2005","unstructured":"Laurino, L. et al. PI3K activation by IGF-1 is essential for the regulation of membrane expansion at the nerve growth cone. J. Cell Sci. 118, 3653\u20133662 (2005).","journal-title":"J. Cell Sci."},{"key":"251_CR16","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1002\/jcp.24607","volume":"229","author":"YS Wang","year":"2014","unstructured":"Wang, Y. S. et al. IGF-1 alleviates NMDA-induced excitotoxicity in cultured hippocampal neurons against autophagy via the NR2B\/PI3K-AKT-mTOR pathway. J. Cell Physiol. 229, 1618\u20131629 (2014).","journal-title":"J. Cell Physiol."},{"key":"251_CR17","first-page":"1749","volume":"34","author":"RY Dai","year":"2009","unstructured":"Dai, R. Y., Chen, R. & Li, H. Cross-talk between PI3K\/Akt and MEK\/ERK pathways mediates endoplasmic reticulum stress-induced cell cycle progression and cell death in human hepatocellular carcinoma cells. Int J. Oncol. 34, 1749\u20131757 (2009).","journal-title":"Int J. Oncol."},{"key":"251_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.canlet.2005.01.051","volume":"228","author":"KK Matthay","year":"2005","unstructured":"Matthay, K. K. et al. Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004. Cancer Lett. 228, 275\u2013282 (2005).","journal-title":"Cancer Lett."},{"key":"251_CR19","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1523\/JNEUROSCI.21-13-04678.2001","volume":"21","author":"GD Cao","year":"2001","unstructured":"Cao, G. D. et al. Caspase-activated DNase\/DNA fragmentation factor 40 mediates apoptotic DNA fragmentation in transient cerebral ischemia and in neuronal cultures. J. Neurosci. 21, 4678\u20134690 (2001).","journal-title":"J. Neurosci."},{"key":"251_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S1535-6108(04)00051-0","volume":"5","author":"C Garcia-Echeverria","year":"2004","unstructured":"Garcia-Echeverria, C. et al. In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase. Cancer Cell 5, 231\u2013239 (2004).","journal-title":"Cancer Cell"},{"key":"251_CR21","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1006\/mcne.1999.0750","volume":"13","author":"EJ Williams","year":"1999","unstructured":"Williams, E. J. & Doherty, P. Evidence for and against a pivotal role of PI 3-kinase in a neuronal cell survival pathway. Mol. Cell Neurosci. 13, 272\u2013280 (1999).","journal-title":"Mol. Cell Neurosci."},{"key":"251_CR22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.nbd.2014.10.025","volume":"73","author":"X Ding","year":"2015","unstructured":"Ding, X. et al. BDNF contributes to the development of neuropathic pain by induction of spinal long-term potentiation via SHP2 associated GluN2B-containing NMDA receptors activation in rats with spinal nerve ligation. Neurobiol. Dis. 73, 428\u2013451 (2015).","journal-title":"Neurobiol. Dis."},{"key":"251_CR23","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/jmg.2011.090282","volume":"48","author":"M Synofzik","year":"2011","unstructured":"Synofzik, M. et al. Acetazolamide-responsive exercise-induced episodic ataxia associated with a novel homozygous DARS2 mutation. J. Med. Genet 48, 713\u2013715 (2011).","journal-title":"J. Med. Genet"},{"key":"251_CR24","doi-asserted-by":"publisher","first-page":"19854","DOI":"10.1073\/pnas.0608397104","volume":"103","author":"C Kowal","year":"2006","unstructured":"Kowal, C. et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc. Natl Acad. Sci. USA 103, 19854\u201319859 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"251_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/art.38900","volume":"67","author":"M Bravo-Zehnder","year":"2015","unstructured":"Bravo-Zehnder, M. et al. Anti-ribosomal P protein autoantibodies from patients with neuropsychiatric lupus impair memory in mice. Arthritis Rheumatol. 67, 204\u2013214 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"251_CR26","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1530\/EJE-18-0042","volume":"178","author":"S Chatterjee","year":"2018","unstructured":"Chatterjee, S. et al. Phenotypic spectrum and responses to recombinant human IGF1 (rhIGF1) therapy in patients with homozygous intronic pseudoexon growth hormone receptor mutation. Eur. J. Endocrinol. 178, 481\u2013489 (2018).","journal-title":"Eur. J. Endocrinol."},{"key":"251_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neubiorev.2016.01.001","volume":"63","author":"J Costales","year":"2016","unstructured":"Costales, J. & Kolevzon, A. The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders. Neurosci. Biobehav. Rev. 63, 207\u2013222 (2016).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"251_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cbi.2010.04.012","volume":"186","author":"RC Soletti","year":"2010","unstructured":"Soletti, R. C. et al. Peptide gomesin triggers cell death through L-type channel calcium influx, MAPK\/ERK, PKC and PI3K signaling and generation of reactive oxygen species. Chem. -Biol. Interact. 186, 135\u2013143 (2010).","journal-title":"Chem. -Biol. Interact."},{"key":"251_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/sj.ki.5002638","volume":"73","author":"E Sarro","year":"2008","unstructured":"Sarro, E. et al. Phosphoinositide 3-kinase inhibitors protect mouse kidney cells from cyclosporine-induced cell death. Kidney Int. 73, 77\u201385 (2008).","journal-title":"Kidney Int."},{"key":"251_CR30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.tox.2009.09.011","volume":"265","author":"HH Park","year":"2009","unstructured":"Park, H. H. et al. L-DOPA-induced neurotoxicity is reduced by the activation of the PI3K signaling pathway. Toxicology 265, 80\u201386 (2009).","journal-title":"Toxicology"},{"key":"251_CR31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neuropharm.2017.09.040","volume":"128","author":"ZY Xie","year":"2018","unstructured":"Xie, Z. Y. et al. Exendin-4 attenuates neuronal death via GLP-1R\/PI3K\/Akt pathway in early brain injury after subarachnoid hemorrhage in rats. Neuropharmacology 128, 142\u2013151 (2018).","journal-title":"Neuropharmacology"},{"key":"251_CR32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejphar.2011.12.032","volume":"677","author":"QG Gao","year":"2012","unstructured":"Gao, Q. G., Xie, J. X., Wong, M. S. & Chen, W. F. IGF-I receptor signaling pathway is involved in the neuroprotective effect of genistein in the neuroblastoma SK-N-SH cells. Eur. J. Pharmacol. 677, 39\u201346 (2012).","journal-title":"Eur. J. Pharmacol."},{"key":"251_CR33","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1074\/jbc.M008552200","volume":"276","author":"A Yamaguchi","year":"2001","unstructured":"Yamaguchi, A. et al. Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53. J. Biol. Chem. 276, 5256\u20135264 (2001).","journal-title":"J. Biol. Chem."},{"key":"251_CR34","doi-asserted-by":"publisher","first-page":"9828","DOI":"10.1074\/jbc.274.14.9828","volume":"274","author":"S Heck","year":"1999","unstructured":"Heck, S., Lezoualc\u2019h, F., Engert, S. & Behl, C. Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappa B. J. Biol. Chem. 274, 9828\u20139835 (1999).","journal-title":"J. Biol. Chem."},{"key":"251_CR35","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/ana.20539","volume":"58","author":"F Blaes","year":"2005","unstructured":"Blaes, F. et al. Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome. Ann. Neurol. 58, 313\u2013317 (2005).","journal-title":"Ann. Neurol."},{"key":"251_CR36","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/brain\/awv324","volume":"139","author":"C Werner","year":"2016","unstructured":"Werner, C. et al. Human autoantibodies to amphiphysin induce defective presynaptic vesicle dynamics and composition. Brain 139, 365\u2013379 (2016).","journal-title":"Brain"},{"key":"251_CR37","doi-asserted-by":"publisher","first-page":"e11124","DOI":"10.1371\/journal.pone.0011124","volume":"5","author":"XY Lu","year":"2010","unstructured":"Lu, X. Y. et al. Anti-alpha-internexin autoantibody from neuropsychiatric lupus induce cognitive damage via inhibiting axonal elongation and promote neuron apoptosis. PLoS ONE 5, e11124 (2010).","journal-title":"PLoS ONE"},{"key":"251_CR38","doi-asserted-by":"publisher","first-page":"6134","DOI":"10.1074\/jbc.M115.655183","volume":"291","author":"AP Gunn","year":"2016","unstructured":"Gunn, A. P. et al. Amyloid-\u03b2 peptide A\u03b23pE-42 induces lipid peroxidation, membrane permeabilization, and calcium influx in neurons. J. Biol. Chem. 291, 6134\u20136145 (2016).","journal-title":"J. Biol. Chem."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41390-018-0251-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-018-0251-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-018-0251-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T11:07:08Z","timestamp":1775300828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-018-0251-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,11]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["251"],"URL":"https:\/\/doi.org\/10.1038\/s41390-018-0251-1","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,11]]},"assertion":[{"value":"5 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}